DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0027765 | nervous system disorder | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0678222 | Breast Carcinoma | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0014070 | Encephalomyelitis | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0036220 | Kaposi Sarcoma | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0025202 | melanoma | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0017638 | Glioma | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C1527336 | Sjogren's Syndrome | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0206062 | Lung Diseases, Interstitial | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C1800706 | Idiopathic Pulmonary Fibrosis | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0014556 | Epilepsy, Temporal Lobe | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0007124 | Noninfiltrating Intraductal Carcinoma | SEMA7A | 8482 | semaphorin 7A (John Milton Hagen blood group) | O75326 |
C0023434 | Chronic Lymphocytic Leukemia | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C1621958 | Glioblastoma Multiforme | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0027651 | Neoplasms | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0949541 | Hurthle Cell Tumor | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C1868683 | B-CELL MALIGNANCY, LOW-GRADE | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0699790 | Colon Carcinoma | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0235974 | Pancreatic carcinoma | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0376358 | Malignant neoplasm of prostate | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0007138 | Carcinoma, Transitional Cell | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C1458155 | Mammary Neoplasms | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0023473 | Myeloid Leukemia, Chronic | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0017638 | Glioma | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C1328840 | Autoimmune Lymphoproliferative Syndrome | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
C0600139 | Prostate carcinoma | HMMR | 3161 | hyaluronan mediated motility receptor | O75330 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024